Evidence map›Paper›PMID 30024926›Full record

ArticlePloS one2018

Tyrosine 870 of TLR9 is critical for receptor maturation rather than phosphorylation-dependent ligand-induced signaling.

Chhanda Biswas, Sheila Rao, Katharine Slade, David Hyman, Devin Dersh, Adriana R Mantegazza, Philip W Zoltick, Michael S Marks, Yair Argon, Edward M Behrens

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Chhanda BiswasDivision of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Sheila RaoDivision of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Katharine SladeDivision of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
David HymanDivision of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Devin DershDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Adriana R MantegazzaDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Philip W ZoltickDivision of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Michael S MarksDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.ORCID 0000-0001-7435-7262
Yair ArgonDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Edward M BehrensDivision of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0002-4603-7963
Children's Hospital of Philadelphia · US

Funding

Platelet granule formation and function in health and diseaseR01HL121323 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI MARKS, MICHAEL S · 2014 to 2017
$1.9M
NHLBI NIH HHS R01 HL121323
6 · The paper itself

Abstract

Toll like receptors (TLRs) share a conserved structure comprising the N-terminal ectodomain, a transmembrane segment and a C-terminal cytoplasmic Toll/IL-1 receptor (TIR) domain. Proper assembly of the TIR domain is crucial for signal transduction; however, the contribution of individual motifs within the TIR domain to TLR trafficking and signaling remains unclear. We targeted a highly conserved tyrosine (Y870) located in the box 1 region of the TIR domain of most TLRs, including TLR9, previously described to be a critical site of phosphorylation in TLR4. We reconstituted bone marrow-derived dendritic cells (BMDC) from Tlr9-/- mice WT TLR9 or Y870F or Y870A mutants. Despite normal interactions with the luminal chaperones GRP94 and UNC93B1, Y870F conferred only partial responsiveness to CpG, and Y870A had no activity and functioned as a dominant negative inhibitor when coexpressed with endogenous TLR9. This loss of function correlated with reduction or absence, respectively, of the 80 kDa mature form of TLR9. In Y870F-expressing cells, CpG-dependent signaling correlated directly with levels of the mature form, suggesting that signaling did not require tyrosine phosphorylation but rather that the Y870F mutation conferred reduced receptor levels due to defective processing or trafficking. Microscopy revealed targeting of the mutant protein to an autophagolysosome-like structure for likely degradation. Collectively we postulate that the conserved Y870 in the TIR domain does not participate in phosphorylation-induced signaling downstream of ligand recognition, but rather is crucial for proper TIR assembly and ER egress, resulting in maturation-specific stabilization of TLR9 within endolysosomes and subsequent pro-inflammatory signaling.

Indexed as

MutationAnimalsCytokinesLigandsMiceMice, Inbred C57BLMice, KnockoutMutagenesis, Site-DirectedPhosphorylationProtein StabilitySignal TransductionToll-Like Receptor 9TyrosineCytokinesLigandsTlr9 protein, mouseToll-Like Receptor 9Tyrosine

Identifiers

PMID30024926
PMCPMC6053202
OpenAlexW2883664967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.